Class 4 Medicines Defect Information: Emerade 150, 300 and 500 microgram solution for injection in pre-filled syringe (MDR 57-08/19)

New feature! Use PharmData's unclaimed EPS scripts tool to identify unclaimed and short-dated EPS prescriptions for your pharmacy, to help streamline your dispensary processes, save money and provide a great service to your patients. Try now for free »

Class 4 Medicines Defect Information: Emerade 150, 300 and 500 microgram solution for injection in pre-filled syringe (MDR 57-08/19)

2019-10-03 11:29:57 (1 year(s) ago)

Summary

The MHRA has notified Bausch and Lomb UK Limited of reports that Emerade pens have failed to activate.

Read full MHRA article

Respond to this alert